Recombinant Human C1QTNF12, N-His from ProteoGenix; catalogue ARO-P12818; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant Human C1QTNF12 (rhC1QTNF12) is a protein that has been artificially produced in a laboratory setting through recombinant DNA technology. This protein belongs to the C1q and TNF-related protein (CTRP) family and has been shown to have various structural and functional properties. In this article, we will discuss the structure, activity, and applications of rhC1QTNF12.
rhC1QTNF12 is a 28 kDa protein that is composed of 247 amino acids. It has a unique three-dimensional structure that is similar to other members of the CTRP family. The protein consists of a globular head domain and a collagen-like tail domain. The head domain is responsible for the protein’s biological activity, while the tail domain provides structural stability.
The head domain of rhC1QTNF12 contains a conserved cysteine knot motif, which is essential for its binding to receptors and other proteins. This domain also contains a hydrophobic pocket that is thought to be involved in the binding of small molecules and lipids. The tail domain, on the other hand, is rich in glycine, proline, and hydroxyproline residues, which give the protein its characteristic triple-helical structure.
rhC1QTNF12 has been shown to have a wide range of biological activities. It has been reported to regulate glucose and lipid metabolism, and has been linked to the development of obesity and type 2 diabetes. Studies have also shown that rhC1QTNF12 plays a role in the regulation of inflammation and immune responses.
One of the main functions of rhC1QTNF12 is its ability to activate the AMP-activated protein kinase (AMPK) pathway. This pathway is involved in the regulation of energy balance and metabolism. Activation of AMPK by rhC1QTNF12 leads to increased glucose uptake and fatty acid oxidation, which can help improve insulin sensitivity and reduce the risk of metabolic disorders.
Additionally, rhC1QTNF12 has been found to have anti-inflammatory properties. It can inhibit the production of pro-inflammatory cytokines and promote the production of anti-inflammatory cytokines. This activity of rhC1QTNF12 may have therapeutic implications in various inflammatory diseases.
The unique structure and biological activities of rhC1QTNF12 make it a promising candidate for various therapeutic applications. One potential application is in the treatment of metabolic disorders such as obesity and type 2 diabetes. Studies have shown that rhC1QTNF12 can improve insulin sensitivity and regulate glucose and lipid metabolism, making it a potential treatment option for these conditions.
In addition, the anti-inflammatory properties of rhC1QTNF12 make it a potential therapeutic agent for inflammatory diseases. It has been shown to have a protective effect in models of inflammatory bowel disease and rheumatoid arthritis. Further research is needed to explore its potential in other inflammatory conditions.
Furthermore, rhC1QTNF12 has been investigated for its role in cancer. Studies have shown that it can inhibit the growth and proliferation of cancer cells, making it a potential anti-cancer agent. However, more research is needed to fully understand its mechanism of action and potential in cancer treatment.
In conclusion, rhC1QTNF12 is a recombinant protein with a unique structure and diverse biological activities. Its role in regulating metabolism, inflammation, and potential in various diseases make it a promising candidate for therapeutic applications. Further research is needed to fully understand its mechanism of action and potential in various conditions.
ProteoGenix catalogue number ARO-P12818. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 18.56 kDa; Fragment: Gly92-Gln241; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
